Occupational Activity – Page 15 – Talk Bio

Actionable Insights Powered by AI

Turnstone Biologics Undergoes Strategic Restructuring with Layoffs and Leadership Changes

7 months ago talkbio0Tagged Arenaria, Biological Factors, Changing, Industry, Leadership, restructuring, strategic

Turnstone Biologics, layoffs, leadership changes, strategic restructuring, biotech industry

Glooko Secures $100 Million Funding to Enhance Diabetes Management Platform Under New Leadership

7 months ago talkbio0Tagged Administration occupational activities, Diabetes, Glooko, Healthcare technology, Leadership

Glooko, diabetes management, healthcare technology, funding, new leadership

Judo Bio Launches with $100M to Pioneer Kidney-Targeted siRNA Therapies

7 months ago talkbio0Tagged genetic medicines, Judo Bio, Kidney Diseases, megalin-STRIKERS, oligonucleotide medicines, RNA, Small Interfering, Strikes, Employee

Judo Bio, siRNA therapies, kidney diseases, oligonucleotide medicines, STRIKE platform, megalin-STRIKERS, renal diseases, genetic medicines.

Optimizing Expression of Multi-chain and Bispecific Antibodies: Strategies and Considerations

7 months ago talkbio0Tagged Antibodies, Antibodies, Bispecific, Cells, Chinese Hamster Ovary, CHO, Cultured Cell Line, expression vector, Metabolic Engineering, Optimization, production, Recombinants, Stable status

Bispecific Antibodies (bsAbs), Recombinant Antibody Production, Chinese Hamster Ovary (CHO) Cells, Expression Vector Optimization, Metabolic Engineering, Stable Cell Line Development

Relay Therapeutics Announces Additional Layoffs to Achieve $50M Annual Savings

7 months ago talkbio0Tagged cost-cutting, Industry, Relay Therapeutics

Relay Therapeutics, layoffs, cost-cutting, biotech industry, workforce reduction

BIOSECURE Act: Navigating Industry Implications and Future Directions

7 months ago talkbio0Tagged BIOSECURE, Biotechnology, capabilities, CDMOs, Chinese Language, Contract agreement, development aspects, Industry, Manufacture, manufacturing organizations, pharmaceutical imports, Pharmaceutical supply chain resilience, Supply chain disruptions, United States

BIOSECURE Act, Biotechnology industry, Supply chain disruptions, Chinese pharmaceutical imports, U.S. manufacturing capabilities, Contract development and manufacturing organizations (CDMOs), Pharmaceutical supply chain resilience

Pharmaceutical Industry Faces Widespread Layoffs Amid Economic Pressures

7 months ago talkbio0Tagged Biopharma, economic pressures, Industry, Pharmaceutical Layoffs, restructuring

pharmaceutical layoffs, economic pressures, biopharma industry, job cuts, restructuring efforts

Travere Therapeutics Pauses Phase 3 HARMONY Study Due to Manufacturing Scale-Up Challenges

7 months ago talkbio0Tagged Homocystinuria, Manufacture, Pegtibatinase, Phase 3 HARMONY Study, Problem, scale-up

Travere Therapeutics, Phase 3 HARMONY Study, Pegtibatinase, Classical Homocystinuria, Manufacturing Scale-Up Issue

Pfizer Generates $2.88 Billion by Selling Off Hundreds of Millions of Haleon Shares

7 months ago talkbio0Tagged Drug Industry, financial, Haleon, News [Publication Type], Pfizer, Sales - occupational activity

Pfizer, Haleon, share sale, pharmaceutical industry, financial news

Metsera and Amneal Collaborate on Next-Generation Obesity Medicines, with Leadership Transition at Metsera

7 months ago talkbio0Tagged Amneal, Leadership, Manufacture, Metsera, Obesity, Partnership, strategic collaboration, Transition Mutation

Metsera, Amneal, Obesity Drugs, Strategic Collaboration, Manufacturing Partnership, Leadership Transition